Last reviewed · How we verify
Levonorgestrel Drug Implant
At a glance
| Generic name | Levonorgestrel Drug Implant |
|---|---|
| Also known as | Jadelle |
| Sponsor | Chulalongkorn University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- SHAPE-ENDO: Multimodal Pre-Surgical Optimization in Patients With Obesity and Early-Stage Endometrial Cancer
- Postplacental Copper Intrauterine Device Versus Postpartum Progesterone-only Pills on Uterine Niche Formation (NA)
- Subdermal Implant-bioabsorbable Gestrinone Pellet for Endometriosis Pelvic Pain Treatment (PHASE2)
- Etonogestrel (ENG) Implant Insertion for Emergency Contraception With Oral Levonorgestrel (LNG) vs Placebo (PHASE4)
- Same Day Oral EC and Implant Initiation
- Kuwa Free! - Live Free! (NA)
- Quick Start of Highly Effective Contraception
- Temporomandibular Disorder in Use of Levonorgestrel Intrauterine System (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Levonorgestrel Drug Implant CI brief — competitive landscape report
- Levonorgestrel Drug Implant updates RSS · CI watch RSS
- Chulalongkorn University portfolio CI